Publisher: Elsevier

Related content
Volume 6, Number 4, 15 February 2001

< previous issue | all issues | next issue >

Favourites:Add to Favourites
Favourites:Add to Favourites

New hope for fungal vaccines?
pp. 163-164(2)
Author: Lawrence, R.N.

Favourites:Add to Favourites

Viral gene therapy for haemophilia
pp. 165-166(2)
Author: Fricker, J.

Favourites:Add to Favourites

Flower power: fact or fiction?
pp. 166-167(2)
Author: Owens, J.

Favourites:Add to Favourites

A budding role for the UPR
pp. 167-168(2)
Author: Dorrell, S.

Favourites:Add to Favourites

News in brief
pp. 169-170(2)
Authors: Owens, J.; Lawrence, R.N.

Favourites:Add to Favourites

People
pp. 171-171(1)
Author: Lawrence

Favourites:Add to Favourites

The optimal fragmentation principle
pp. 175-175(1)
Author: Johnson, D.E.

Favourites:Add to Favourites

More clinical input required for R&D decision-making?
pp. 175-176(2)
Author: Jain, K.K.

Favourites:Add to Favourites

Optimizing screening technology: how much to invest? - Reply
pp. 176-177(2)
Author: Glickman, J.F.

Favourites:Add to Favourites

Nucleic Acids: Structures, Properties and Functions
pp. 178-179(2)
Author: demidov, V.V.

Favourites:Add to Favourites
Favourites:Add to Favourites

Developing non-viral DNA delivery systems for cancer and infectious disease
pp. 186-197(12)
Authors: Spack, E.G.; Sorgi, F.L.

Favourites:Add to Favourites
Favourites:Add to Favourites

Monitor: molecules and profiles
pp. 213-216(4)
Author: Walker, M.A.

Favourites:Add to Favourites

Novel antitumour molecules
pp. 215-216(2)
Author: Westwell, A.

Favourites:Add to Favourites

Drug delivery
pp. 216-217(2)
Author: Weidner, J.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more